169 Yb‐based rotating shield brachytherapy for prostate cancer

Quentin Adams,Karolyn M. Hopfensperger,Yusung Kim,Xiaodong Wu,Ryan T. Flynn
DOI: https://doi.org/10.1002/mp.14533
IF: 4.506
2020-11-01
Medical Physics
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>To present a system for the treatment of prostate cancer in a single‐fraction regimen using <sup>169</sup>Yb‐based rotating shield brachytherapy (RSBT) with a single‐catheter robotic delivery system. The proposed system is innovative because it can deliver RSBT through multiple implanted needles independently, in serial, using flexible catheters, with no inter‐needle shielding effects and without the need to rotate multiple shielded catheters inside the needles simultaneously, resulting in a simple, mechanically robust, delivery approach. RSBT was compared to conventional <sup>192</sup>Ir‐based high‐dose‐rate brachytherapy (HDR‐BT) in a treatment planning study with dose escalation and urethral sparing goals, representing single‐fraction brachytherapy monotherapy and brachytherapy as a boost to external beam radiotherapy, respectively. A prototype mechanical delivery system was constructed and quantitatively evaluated as a proof of concept. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Treatment plans for twenty‐six patients with single fraction prescriptions of 20.5 Gy and 15 Gy, were created for dose escalation and urethral sparing, respectively. The RSBT and HDR‐BT delivery systems were modeled with one partially‐shielded 999 GBq (27 Ci) <sup>169</sup>Yb source and one 370 GBq (10 Ci) <sup>192</sup>Ir source, respectively. A prototype angular drive system for helical source delivery was constructed. Mechanical accuracy measurements of source translational position and angular orientation in a simulated treatment delivery setup were obtained using the prototype system. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>For dose escalation, with equivalent urethra <i>D</i><sub>10%</sub>, PTV <i>D</i><sub>90%</sub> for RSBT versus HDR‐BT increased from 22.6 ± 0.0 Gy (average ± standard deviation) to 29.3 ± 0.9 Gy, or 29.9 % ± 3.0%, with treatment times of 51.4 ± 6.1 minutes for RSBT and 15.8 ± 2.3 minutes for 10 Ci <sup>192</sup>Ir‐based HDR‐BT. For urethra sparing, with equivalent PTV <i>D<sub>90</sub></i><sub>%</sub>, urethra <i>D</i><sub>10%</sub> for RSBT versus HDR‐BT decreased for RSBT versus HDR‐BT from 15.6 ± 0.4 Gy to 12.0 ± 0.4 Gy, or 23.1% ± 3.5%, with treatment times of 30.0 ± 3.7 minutes for RSBT and 12.3 ± 1.8 minutes for HDR‐BT. Differences between measured versus predicted rotating catheter positions (corresponding to source position) were within 0.18 mm ± 0.12 mm longitudinally and 0.07° ± 0.78°. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p><sup>169</sup>Yb‐based RSBT can increase PTV <i>D</i><sub>90%</sub> or decrease urethral <i>D</i><sub>10%</sub> relative to HDR‐BT with treatment times of less than one hour using a single source robotic delivery system with treatment delivered in a single fraction. The prototype helical delivery system was able to demonstrate adequate mechanical accuracy. </p></section>
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?